Shaping immunotherapy with customized cytokine solutions to improve patient outcomes.

About us

Shaping immunotherapy with customized cytokine solutions to improve patient outcomes.

About us

Welcome to ARSCience Biotherapeutics, a clinical stage biotech company that specializes in developing and manufacturing customized interleukins for in vivo use.

News
MedicineJune 7, 2023

Coya Therapeutics, Inc. Announces Expansion of Exclusive Worldwide Licensing Agreement with ARScience Biotherapeutics, Inc.

Read more →
InnovationApril 18, 2023

Arscience Biotherapeutics announces new CEO

Read more →
01 / 02

ARScience Bio’s team has over 20 years of experience in cytokine and immunomodulator development and manufacturing. We have built strong partnerships with leading academic institutions and clinical groups to develop novel indications for our portfolio of products.